Skip to content

Author

Chang-Jiao Yan

We have 3 of 34 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase.

BACKGROUND Dysregulated lipid metabolism and chemoresistance are key drivers of breast cancer progression. Lectin, mannose-binding 2 (LMAN2) is frequently overexpressed in human breast tumors and functions as an oncogenic driver. However, whether LMAN2 contributes to chemoresistance remains unknown. METHODS We integr...

Changjiao Yan, Fengqiang Cui, Chutuo Liu et al. · 0 citations
Open access Jul 2026

Clinical and pathological profile with prognostic insights in 9504 thyroid cancer cases: a single-center study (2008-2023)

Abstract Background Thyroid cancer incidence is rising worldwide, yet comprehensive longitudinal data linking contemporary demographic, pathological, and surgical trends to recurrence risk remain scarce. Methods A retrospective analysis was performed on 9504 thyroid cancer patients from 2008 to 2023. Based on the year...

Sijin Guo, Yang Wang, Changjiao Yan et al. · 0 citations
Open access Jul 2026

NSUN2 regulates PARP9 progression through m5C modification to mediate breast cancer progression.

BACKGROUND m5C modification plays a vital role in the progression of human cancers, including breast cancer (BC), but the function of NOP2/Sun RNA methyltransferase 2 (NSUN2), an RNA m5C modification enzyme, remains largely unclear. METHODS qRT-PCR, western blot and IHC assays were carried out to determine the expres...

Xin Li, Changjiao Yan, Jun Yi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.